COVID: Experimental Drug Remdesivir Gives Hope

FRANCE 24 / YouTube / FDA

NEW YORK – Right now, health experts are working around the clock to find a treatment for the Coronavirus, and a doctor leading up a clinical trial for a drug called Remdesivir says they’re getting good results.

Doctor Kathleen Mullane said COVID-19 patients who have been getting it have been recovering quickly with most going home in less than a week.







Stat news reported the latest findings after getting a video of a conversation about the trial.

Initially, Remdesivir was tested to see if it could help people who had the Ebola Virus but it didn’t do much.





Multiple studies in animals showed the drug could prevent and treat coronaviruses related to COVID-19, with the World Health Organization pointing to its potential back in February.

According to a video stat obtained, Doctor Mullane said most of their patients were severe and most of them are leaving after 6 days of treatment.













To be clear, there’s no control group in this study so everyone is getting the drug which means it’s hard to point to the drug itself causing their improvement.

Although, there are hundreds of trial sites around the world right now and thousands are part of the study.

So the company who makes it, Gilead, said it expected results from the trial by the end of the month.

 

Make it easy to keep up to date with more stories like this. Download the WNY News Now mobile app on the Apple App Store and Google Play Store.

 

Have a news tip? Email newsdesk@WNYNewsNow.com, send us a message on Facebook, or Twitter.

WNY News Now encourages an open exchange of opinions and ideas on our stories, however, we ask everyone to follow our comment policy.

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.